The Role of Therapeutic Plasma Exchange in Poisonings and Intoxications

Seminars in Dialysis

Volumn 25, Issue 2, 2012, Pages 201-206

  Schutt, Robert Clark ^a   Ronco, Claudio ^b   Rosner, Mitchell H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; CISPLATIN; VENOM;

ARTICLE; COMPARATIVE STUDY; CRITICAL ILLNESS; DRUG TOXICITY; FEMALE; HUMAN; INTENSIVE CARE; INTOXICATION; MALE; METHODOLOGY; MORTALITY; MUSHROOM POISONING; PLASMAPHERESIS; PRACTICE GUIDELINE; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

BIOLOGICAL AGENTS; CISPLATIN; CRITICAL CARE; CRITICAL ILLNESS; DRUG TOXICITY; FEMALE; HUMANS; MALE; MUSHROOM POISONING; OVERDOSE; PLASMA EXCHANGE; POISONING; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; VENOMS;

EID: 84858707274     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.01033.x     Document Type: Article

References (107)

1. Bronstein AC, Spyker DA, Cantilena LR, Green JL, Rumack BH, Giffin SL: 2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report. Clin Toxicol (Phila) 48(10):979-1178, 2010
2. Abel JJ, Rowntree LG, Turner BB: Plasma removal with return of corpuscles (plasmapheresis). J Pharm Exper Ther 5(6):625-641, 1914
3. Seyffart G: Plasmapheresis in treatment of acute intoxications. Trans Am Soc Artif Organs 28:673-676, 1982
4. Sketris IS, Parker WA, Jones JV: Effect of plasma exchange on drug removal. In: Valbonesi M, Pineda AA, Biggs JC (eds). Therapeutic Hemapheresis, Milan: Wichtig Editore, 1986:15-20
5. Silber B, Lo M, Riegelman S: The influence of heparin administration on the plasma protein binding and disposition of propranolol. Res Commun Chem Pathol Pharmacol 27(3):419-429, 1980
6. Jones JS, Dougherty J: Current status of plasmapheresis in toxicology. Ann Emerg Med 15(4):474-482, 1986
7. Calvo R, Aguilera L, Aguirre C, Rodriguez Sasiain JM: Effect of heparin administration on flunitrazepam protein binding. Int J Clin Pharmacol Res 9(1):59-63, 1989
8. Kaplan AA: A Practical Guide to Therapeutic Plasma Exchange. Malden, MA: Wiley-Blackwell, 1999:214-233
9. McLeod BC, Weinstein R, Price TH, Weinstein RA: Apheresis: Principles and Practice. Bethesda, MD: AABB Press, 2003:392-407
10. Gibson TP: Kinetics of drug removal. Trans Am Soc Art Int Organs 28:672, 1982
11. Szczepiorkowski ZM, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Shaz BH, Weinstein R, Wirk A, Winters JL, American Society for Apheresis, Apheresis Applications Committee of the American Society for Apheresis: Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 22(3):106-175, 2007
12. Winchester JF: Poisoning: is the role of the nephrologist diminishing? Am J Kidney Dis 13(3):171-183, 1989
13. Vesconi S, Langer M, Iapichino G, Costantino D, Busi C, Fiume L: Therapy of cytotoxic mushroom intoxication. Crit Care Med 13(5):402-406, 1985
14. Becker CE, Tong TG, Boerner U, Roe RL, Scott AT, MacQuarrie MB, Bartter F: Diagnosis and treatment of Amanita phalloides-type mushroom poisoning: use of thioctic acid. West J Med 125(2):100-109, 1976
15. Karlson-Stiber C, Persson H: Cytotoxic fungi-an overview. Toxicon 42(4):339-349, 2003
16. Wieland T: The toxic peptides from Amanita mushrooms. Int J Pept Protein Res 22(3):257-276, 1983
17. Wieland T: Poisonous principles of mushrooms of the genus Amanita. Four-carbon amines acting on the central nervous system and cell-destroying cyclic peptides are produced. Science 159(818):946-952, 1968
18. Floersheim GL, Weber O, Tschumi P, Ulbrich M: Clinical death-cap (Amanita phalloides) poisoning: prognostic factors and therapeutic measures. Analysis of 205 cases. Schweiz Med Wochenschr 112(34):1164-1177, 1982
19. Jander S, Bischoff J, Woodcock BG: Plasmapheresis in the treatment of Amanita phalloides poisoning: II. A review and recommendations. Ther Apher 4(4):308-312, 2000
20. Brent J, Palmer R: Chapter 23: Mushrooms. In: Shannon MW, Borron SW, Burns M (eds). Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose, West Palm Beach: Saunders, 2007
21. Jander S, Bischoff J: Treatment of Amanita phalloides poisoning: I. Retrospective evaluation of plasmapheresis in 21 patients. Therap Apher 4(4):303-307, 2000
22. Fiume L, Sperti S, Montanaro L, Busi C, Costantino D: Amanitins do not bind to serum albumin. Lancet 1(8021):1111, 1977
23. Ronco C, Bellomo R, Kellum J: Critical Care Nephrology. Philadelphia: Saunders, 2008:926-932
24. Hollman A: Drugs for atrial fibrillation. Digoxin comes from Digitalis lanata. BMJ 312(7035):912, 1996
25. Ordog GJ, Benaron S, Bhasin V, Wasserberger J, Balasubramanium S: Serum digoxin levels and mortality in 5, 100 patients. Ann Emerg Med 16(1):32-39, 1987
26. Rosegger H, Zach M, Gleispach H, Beitzke A: Digoxin elimination by exchange transfusion. Eur J Pediatr 124(3):217-222, 1977
27. Hickey AR, Wenger TL, Carpenter VP, Tilson HH, Hlatky MA, Furberg CD, Kirkpatrick CH, Strauss HC, Smith TW: Digoxin immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study. J Am Coll Cardiol 17(3):590-598, 1991
28. Mehta RN, Mehta NJ, Gulati A: Late rebound digoxin toxicity after digoxin-specific antibody Fab fragments therapy in anuric patient. J Emerg Med 22(2):203-206, 2002
29. Santos-Araujo C, Campos M, Gavina C, Rocha-Goncalves F, Pestana M: Combined use of plasmapheresis and antidigoxin antibodies in a patient with severe digoxin intoxication and acute renal failure. Nephrol Dial Transplant 22(1):257-258, 2007
30. Kornalik F, Vorlova Z: Non-specific therapy of a hemorrhagic diathesis after a bite by a young Bothrops asper (barba amarilla): a case report. Toxicon 28(12):1497-1501, 1990
31. Laothong C, Sitprija V: Decreased parasympathetic activities in Malayan krait (Bungarus candidus) envenoming. Toxicon 39(9):1353-1357, 2001
32. Malina T, Krecsak L, Korsos Z, Takacs Z: Snakebites in Hungary-epidemiological and clinical aspects over the past 36years. Toxicon 51(6):943-951, 2008
33. Cobcroft RG, Williams A, Cook D, Williams DJ, Masci P: Hemolytic uremic syndrome following taipan envenomation with response to plasmapheresis. Pathology 29(4):399-402, 1997
34. Isbister GK, Little M, Cull G, McCoubrie D, Lawton P, Szabo F, Kennedy J, Trethewy C, Luxton G, Brown SG, Currie BJ: Thrombotic microangiopathy from Australian brown snake (Pseudonaja) envenoming. Intern Med J 37(8):523-528, 2007
35. Keyler DE: Envenomation by the lowland viper (Proatheris superciliaris): severe case profile documentation. Toxicon 52(8):836-841, 2008
36. Hoffman R, Benz E, Shattil S, Furie B, Silberstein LE, McGlave P, Heslop H: Hematology: Basic Principles and Practice. Philadelphia: Churchill Livingstone, 2009
37. Brivet F, Pavlovitch JM, Gouyette A, Cerrina ML, Tchernia G, Dormont J: Inefficiency of early prophylactic hemodialysis in cis-platinum overdose. Cancer Chemother Pharmacol 18(2):183-184, 1986
38. Lagrange JL, Cassuto-Viguier E, Barbé V, Fischel JL, Mondain JR, Etienne MC, Ferréro JM, Creisson-Ducray A, Formento P, Milano G: Cytotoxic effects of long-term circulating ultrafiltrable platinum species and limited efficacy of haemodialysis in clearing them. Eur J Cancer 30(14):2057-2060, 1994
39. Chu G, Mantin R, Shen YM, Baskett G, Sussman H: Massive cisplatin overdose by accidental substitution for carboplatin. Toxicity and management. Cancer 72(12):3707-3714, 1993
40. Choi JH, Oh JC, Kim KH, Chong SY, Kang MS, Oh DY: Successful treatment of cisplatin overdose with plasma exchange. Yonsei Med J 43(1):128-132, 2002
41. Yamada Y, Ikuta Y, Nosaka K, Miyanari N, Hayashi N, Mitsuya H, Baba H: Successful treatment of Cisplatin overdose with plasma exchange. Case Report Med 2010:802312, 2010
42. Hofmann G, Bauernhofer T, Krippl P, Lang-Loidolt D, Horn S, Goessler W, Schippinger W, Ploner F, Stoeger H, Samonigg H: Plasmapheresis reverses all side-effects of a cisplatin overdose-a case report and treatment recommendation. BMC Cancer 6:1, 2006
43. Rudick RA, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Radue EW, Lublin FD, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA, Sandrock AW, SENTINEL Investigators: Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med 354(9):911-923, 2006
44. Khatri BO, Man S, Giovannoni G, Koo AP, Lee JC, Tucky B, Lynn F, Jurgensen S, Woodworth J, Goelz S, Duda PW, Panzara MA, Ransohoff RM, Fox RJ: Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology 72(5):402-409, 2009
45. Clifford DB, De Luca A, Simpson DM, Arendt G, Giovannoni G, Nath A: Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 9(4):438-446, 2010
46. Linda H, von Heijne A, Major EO, Ryschkewitsch C, Berg J, Olsson T, Martin C: Progressive multifocal leukoencephalopathy after natalizumab monotherapy. N Engl J Med 361(11):1081-1087, 2009
47. Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R: Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 361(11):1075-1080, 2009
48. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH, Apheresis Applications Committee of the American Society for Apheresis: Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 25(3):83-177, 2010
49. Diaz-Sanchez CL, Lifshitz-Guinzberg A, Ignacio-Ibarra G, Halabe-Cherem J, Quinones-Galvan A: Survival after massive (>2000) Africanized honeybee stings. Arch Intern Med 158(8):925-927, 1998
50. Langer M, Vesconi S, Iapichino G, Costantino D, Radrizzani D: The early removal of amatoxins in the treatment of Amanita phalloides poisoning (author's transl). Klin Wochenschr 58(3):117-123, 1980
51. Mercuriali F, Sirchia G: Plasma exchange for mushroom poisoning. Transfusion 17(6):644-646, 1977
52. Mikos B, Biro E: Amanita phalloides poisoning in a 15-year case load of a pediatric intensive care unit. Orv Hetil 134(17):907-910, 1993
53. Fort J, Rodriguez JA, Cantarell C, Bartolome J, Boveda JL, Olmos A, Piera L: Plasmapheresis in Amanita phalloides poisoning. Med Clin 82(17):748-750, 1984
54. Rode P, Horvat M, Pance I, Jamsek M, Krejci F: Zastrupitev z zeleno musnico (Amanita phalloides): Kratek pregled literature in prikaz lastnih primerov v letih 1979-1982. Zdrav Vestn 52:401-404, 1983
55. Mydlik M, Derzsiova K, Mizla P, Beno P: Hemoperfusion in mushroom poisoning. Clinical analysis of 58 patients. Cas Lek Cesk 132(15):464-467, 1993
56. Yildiz BD, Abbasoglu O, Saglam A, Sokmensuer C: Urgent liver transplantation for Amanita phalloides poisoning. Pediatr Transplant 12(1):105-108, 2008
57. Rubik J, Grenda R, Prokurat S, Jobs K, Smirska E, Latoszynska J, Litwin M, Materna B, Rychlik G: Clinical aspects of plasmapheresis therapy in children: single center experience. Pol Merkur Lekarski 14(82):304-310, 2003
58. St Nenov D, Sv Nenov K: Therapeutic apheresis in exogenous poisoning and in myeloma. Nephrol Dial Transplant 16(Suppl. 6):101-102, 2001
59. Russo GE, Giusti S, Maurici M, Bosco M, Vitaliano E, Caramiello MS, Bauco B, De Marco CM, Marigliano V: Plasmapheresis and mushroom poisoning: report of a case of Amanita phalloides poisoning. Clin Ter 148(5-6):277-280, 1997
60. Kolsal E, Tekin IO, Piskin E, Aydemir C, Akyuz M, Cabuk H, Eldes N, Numanoglu V: Treatment of severe amitriptyline intoxication with plasmapheresis. J Clin Apher 24(1):21-24, 2009
61. Bayrakci B, Unal S, Erkocoglu M, Güngör HY, Aksu S: Case reports of successful therapeutic plasma exchange in severe amitriptyline poisoning. Therap Apher Dial 11(6):452-454, 2007
62. Belen B, Akman A, Yüksel N, Dilsiz G, Yenicesu I, Olguntürk R: A case report of amitriptyline poisoning successfully treated with the application of plasma exchange. Therap Apher Dial 13(2):147-149, 2009
63. Atabek ME, Yavuz H, Oran B, Karaaslan S, Erkul I: Plasmapheresis as an adjunct treatment in severe botulism. Intensive Care Med 28(6):814, 2002
64. Paterson DL, King MA, Boyle RS, Pond SM, Whitby M, Wright M, Henderson A: Severe botulism after eating home-preserved asparagus. Med J Aust 157(4):269-270, 1992
65. Rapoport S, Watkins PB: Descending paralysis resulting from occult wound botulism. Ann Neurol 16(3):359-361, 1984
66. Duzova A, Baskin E, Usta Y, Ozen S: Carbamazepine poisoning: treatment with plasma exchange. Hum Exp Toxicol 20(4):175-177, 2001
67. Gambi D, Oggioni R, Mangani V, Librenti M, Manescalchi F, Tulli G: Acute carbamazepine poisoning treated with plasmapheresis. Description of a clinical case. Minerva Anestesiol 59(10):547-552, 1993
68. Tibballs J: Acute toxic reaction to carbamazepine: clinical effects and serum concentrations. J Pediatr 121(2):295-299, 1992
69. Kale PB, Thomson PA, Provenzano R, Higgins MJ: Evaluation of plasmapheresis in the treatment of an acute overdose of carbamazepine. Ann Pharmacother 27(7-8):866-870, 1993
70. Minami M, Katsumata M, Miyake K, Inagaki H, Fan XH, Kubota H, Yamano Y, Kimura O: Dangerous mixture of household detergents in an old-style toilet: a case report with simulation experiments of the working environment and warning of potential hazard relevant to the general environment. Hum Exp Toxicol 11(1):27-34, 1992
71. Delpech N, Rapior S, Donnadieu P, Cozette AP, Ortiz JP, Huchard G: Voluntary poisoning by Cortinarius orellanus: usefulness of an original early treatment after determination of orellanine in the biological fluids and tissues. Nephrologie 12(2):63-66, 1991
72. Hayakawa M: Severe hepatic dysfunction following cresol poisoning. Intensive Care Med 28(8):1190-1191, 2002
73. Illner N, Gerth J, Pfeiffer R, Bruns T, Wolf G: "Nearly a stairway to heaven"-severe dichromate intoxication in a young man. Clin Nephrol 71(3):338-341, 2009
74. Rabetoy GM, Price CA, Findlay JW, Sailstad JM: Treatment of digoxin intoxication in a renal failure patient with digoxin-specific antibody fragments and plasmapheresis. Am J Nephrol 10(6):518-521, 1990
75. Heesen H, Lahrtz H: Treatment of severe digitalis-intoxication in suicidal attempt (author's transl). Med Klin 70(18):812-816, 1975
76. Lalanne B: Digitalis poisoning in a patient with septic shock: value of plasma exchange. La Presse médicale (1983) 25(24):1125, 1996
77. Chillet P, Korach JM, Petitpas D, Vincent N, Poiron L, Barbier B, Boazis M, Berger PH: Digoxin poisoning and anuric acute renal failure: efficiency of the treatment associating digoxin-specific antibodies (Fab) and plasma exchanges. Int J Artif Organs 25(6):538-541, 2002
78. Zdunek M, Mitra A, Mokrzycki MH: Plasma exchange for the removal of digoxin-specific antibody fragments in renal failure: timing is important for maximizing clearance. Am J Kidney Dis 36(1):177-183, 2000
79. Unal S, Bayrakci B, Yasar U, Karagoz T: Successful treatment of propafenone, digoxin and warfarin overdosage with plasma exchange therapy and rifampicin. Clin Drug Inv 27(7):505-508, 2007
80. Arsac P: Digitalis poisoning treated by plasma exchange. La Nouvelle presse médicale 9(41):3097, 1980
81. Gutschmidt HJ: Successful plasmapheresis in severe diltiazem poisoning. Dtsch Med Wochenschr 120(3):81-82, 1995
82. Bernscherer G, Prinz G: Successful treatment of acute ethylene glycol poisoning with plasmapheresis. Orv Hetil 139(31):1857-1859, 1998
83. Humberston CL, Akhtar J, Krenzelok EP: Acute hepatitis induced by kava kava. J Toxicol Clin Toxicol 41(2):109-113, 2003
84. Rund D, Schaap T, Da'as N, Ben Yehuda D, Kalish J: Plasma exchange as treatment for Lawsone (henna) intoxication. J Clin Apher 22(4):243-245, 2007
85. Beigmohammadi MT, Aghdashi M, Najafi A, Mojtahedzadeh M, Karvandian K: Quadriplegia due to lead-contaminated opium-case report. Middle East J Anesthesiol 19(6):1411-1416, 2008
86. Binimelis J: Massive thyroxine intoxication: evaluation of plasma extraction. Intensive Care Med 13(1):33-38, 1987
87. Siegenbeek Van Heukelom LH, der Kinderen PJ, Vingerhoeds ACM: Plasmapheresis in L-thyroxine intoxication. Plasma Ther 1(4):33-37, 1980
88. Kalabalikis P, Hatzis T, Papadatos J, Gionis D, Danou F, Vlachos P: Paraquat poisoning in a family. Vet Hum Toxicol 43(1):31-33, 2001
89. Tsatsakis AM, Perakis K, Koumantakis E: Experience with acute paraquat poisoning in Crete. Vet Hum Toxicol 38(2):113-117, 1996
90. Carballo Fernandez C, Murias Taboada E, Vila Fernandez D, Guillen Vazquez MJ, Pena Marcos F, Amador Barciela L: Pentachlorophenol poisoning. Report of 4 cases and review of the literature. An Med Interna 17(5):257-260, 2000
91. Emet M, Aslan S, Cakir ZG, Uyanik A, Uzkeser M, Hacimuftuoglu A, Emre H: Plasmapheresis is useful in phenprobamate overdose. Am J Emerg Med 27(5):626.e1-626.e2, 2009
92. Ogura M, Ohbu S, Ohiwa T, Hayashida N, Honda M: A successful case of hollow-fiber plasmapheresis for prolonged phenytoin intoxication. Nippon Naika Gakkai Zasshi 78(8):1194-1198, 1989
93. Larsen LS, Sterrett JR, Whitehead B, Marcus SM: Adjunctive therapy of phenytoin overdose-a case report using plasmaphoresis. J Toxicol Clin Toxicol 24(1):37-49, 1986
94. Kolcz J, Pietrzyk J, Januszewska K, Procelewska M, Mroczek T, Malec E: Extracorporeal life support in severe propranolol and verapamil intoxication. J Intensive Care Med 22(6):381-385, 2007
95. Blum SF, Lessig MA: Plamapheresis in quinidine purpura. Plasma Ther 1:65, 1980
96. Sabto JK, Pierce RM, West RH, Gurr FW: Hemodialysis, peritoneal dialysis, plasmapheresis and forced diuresis for the treatment of quinine overdose. Clin Nephrol 16(5):264-268, 1981
97. Hastings D, Patel B, Torloni AS, Mookadam F, Betcher J, Moss A, Heilman R, Mazur M, Hamawi K, Mulligan D, Reddy K, Mekeel K, Chakkera H: Plasmapheresis therapy for rare but potentially fatal reaction to rituximab. J Clin Apher 24(1):28-31, 2009
98. Yildirim C, Bayraktaroglu Z, Gunay N, Bozkurt S, Kose A, Yilmaz M: The use of therapeutic plasmapheresis in the treatment of poisoned and snake bite victims: an academic emergency department's experiences. J Clin Apher 21(4):219-223, 2006
99. Steffen C, Seitz R: Severe chlorate poisoning: report of a case. Arch Toxicol 48:281-288, 1981
100. Itoh Y, Nagaki S, Kuyama N, Hirano K, Sunahara M, Funatsuka M, Yanagaki S, Yoshida M, Hirano Y, Osawa M, Fukuyama Y: A case of acute theophylline intoxication with repeated status convulsivus. No To Hattatsu 31(6):559-564, 1999
101. Laussen P, Shann F, Butt W, Tibballs J: Use of plasmapheresis in acute theophylline toxicity. Crit Care Med 19(2):288-290, 1991
102. Siebenlist D: Plasma separation in verapamil poisoning. Dtsch Med Wochenschr 115(20):797, 1990
103. Kuhlmann U, Schoenemann H, Muller TF, Keuchel M, Lange H: Plasmapheresis in fatal overdose with verapamil. Intensive Care Med 25(12):1473, 1999
104. Lotz JP, Chapiro J, Voinea A, Cornu P, Pene F, Bazelly B, Similowski T, Derquenne F: Overdosage of vinorelbine in a woman with metastatic non-small-cell lung carcinoma. Ann Oncol 8(7):714-715, 1997
105. Pierga JY, Beuzeboc P, Dorval T, Palangie T, Pouillart P: Favourable outcome after plasmapheresis for vincristine overdose. Lancet 340(8812):185, 1992
106. Spiller M, Marson P, Perilongo G, Farina M, Carli M, Bisogno G: A case of vinblastine overdose managed with plasma exchange. Pediatr Blood Cancer 45(3):344-346, 2005
107. Leopold NA, Bara-Jimenez W, Hallett M: Parkinsonism after a wasp sting. Mov Disord 14(1):122-127, 1999